Folate is an essential nutrient used for adequate nutrition, deficiency treatment and pregnancy-related prevention. Routine supplementation has not been shown to extend life in well-nourished adults. Benefits depend on the condition being treated; selected adults with high blood pressure and low folate may benefit. Total exposure, vitamin B12 status and medication interactions matter. Methylfolate has not demonstrated superior long-term outcomes. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Serum folate | >4.7 ng/mL (standard reference range) | Expected replacement response |
| Serum vitamin B12 | 180–914 ng/L (standard reference range) | Safety: deficiency changes folate-only use |
| Methylmalonic acid | 0.00–0.40 micromol/L (standard reference range) | Clarifies suspected B12 deficiency |
| Hemoglobin within the blood count | Adult men 13.2–16.6 g/dL; adult women 11.6–15.0 g/dL (standard reference ranges) | Expected anemia response |
| Homocysteine, when initially elevated | <10 micromol/L (standard reference range; not a validated longevity target) | Expected biochemical response |
| Kidney filtration, when kidney disease or high-dose combinations are relevant | No established target; track change from the individual's baseline | Safety: deterioration changes regimen assessment |
Cadence: Deficiency treatment, common practice: blood count around two weeks; reassessment at six to eight weeks and four months; persistent causes every six to twelve months. Not validated longevity schedules. Routine panels are not established for asymptomatic adults meeting dietary requirements.